Danaher Corp. engages in the design, manufacture, and marketing of professional, medical, industrial, and commercial products and services. The company is headquartered in Washington, Washington Dc and currently employs 61,000 full-time employees. The firm operates through three segments: Biotechnology, Life Sciences and Diagnostics. The Biotechnology segment includes the bioprocessing and discovery and medical businesses and offers a broad range of equipment, consumables and services that are primarily used by customers to advance and accelerate the research, development, manufacture and delivery of biological medicines. The Life Sciences segment offers a broad range of instruments, consumables, services and software that are primarily used by customers to study the basic building blocks of life, including deoxyribonucleic acid (DNA) and ribonucleic acid (RNA), nucleic acid, proteins, metabolites and cells. The Diagnostics segment offers clinical instruments, consumables, software and services that hospitals, physicians’ offices, reference laboratories and other critical care settings use to diagnose disease and make treatment decisions.
Danaher Corp hisse başına yıllık % {var1} temettüye sahiptir ve % {var2} oranında bir getiri sunmaktadır. Temettü üç ayda bir ödenmektedir ve son temettü hariç tarihi Dec 26, 2025 tarihindedir.
Dividend Yield
Yıllık Dividende
Özsermaye Tarihi
0.00%
$1.28
Dec 26, 2025
Ödeme Sıklığı
Ödeme Oranı
Üç ayda bir
0.00%
Dividend History
Özsermaye Tarihi
Nakit Tutarı
Kayıt Tarihi
Ödeme Tarihi
Dec 26, 2025
$0.32
Dec 26, 2025
Jan 30, 2026
Sep 26, 2025
$0.32
Sep 26, 2025
Oct 31, 2025
Jun 27, 2025
$0.32
Jun 27, 2025
Jul 25, 2025
Mar 28, 2025
$0.32
Mar 28, 2025
Apr 25, 2025
Dec 27, 2024
$0.27
Dec 27, 2024
Jan 31, 2025
Sep 27, 2024
$0.27
Sep 27, 2024
Oct 25, 2024
Dividend Grafikleri
DHR Kâr Payları
DHR Dividend Growth (Yıllık Üstünlük)
Follow-Up Questions
Danaher Corp'in şu anki temettü ödemesi ve yıllık temettüsü nedir?